Disclosure for clinical trial participants is typically governed by the trial protocol and informed consent
Its possible that certain foods, like ones with lots of spice or fatty foods, may trigger adverse reactions in patients who take GLP-1s
Theres no one-size-fits-all decision
X., Cao, Y., Yu, X., Samuel, R., Ali, B., Desiderio, R., Cholankeril, G., & Bajaj, M
[19] Who Is Most at Risk of This Side Effect Individuals with pre-existing tachycardia, arrhythmias, hyperthyroidism, or heart failure, and those taking sympathomimetics or SNRIs, are most likely to require closer cardiac monitoring during retatrutide treatment
Retatrutide is a once-weekly injection still in clinical trials -but early results (up to 24% body weight loss in 11 months ) are drawing comparisons to bariatric surgery